Author Correction: Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination
1 Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
2 Alliance Laboratory for Advanced Medical Research, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
3 Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
4 Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
5 Clinical Bio-Resource Center, Kyoto University Hospital, Kyoto, Japan.
6 Department of Early Clinical Development, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
7 Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, Japan.
8 Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
9 Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. yoko.hamazaki@cira.kyoto-u.ac.jp.
10 Laboratory of Immunobiology, Graduate school of Medicine, Kyoto University, Kyoto, Japan. yoko.hamazaki@cira.kyoto-u.ac.jp.